Structural Insights and Molecular Docking of Tyrosine Phosphatase (LTP-1) for Novel Anti-Periodontal Peptides Targeting Porphyromonas gingivalis.
Keywords:
Porphyromonas gingivalis, Tyrosine Phosphatase, LTP-1, Molecular Docking, Antimicrobial Peptides, Periodontitis, ClusPro.Abstract
Periodontal diseases are chronic inflammatory conditions primarily driven by pathogenic bacteria such as Porphyromonas gingivalis, a keystone pathogen implicated in tissue destruction and immune dysregulation. Targeting bacterial virulence factors, particularly enzymatic regulators such as tyrosine phosphatases, offers a promising therapeutic strategy. Low molecular weight tyrosine phosphatase (LTP-1) plays a critical role in bacterial signaling, adhesion, and pathogenicity. The present study aimed to investigate the structural characteristics of LTP-1 and evaluate potential antimicrobial peptides (AMPs) targeting this protein through molecular docking approaches. The three-dimensional structure of LTP-1 was retrieved and refined using established protein databases. Candidate antimicrobial peptides were selected from curated peptide repositories based on their reported antibacterial activity. Molecular docking was performed using ClusPro to predict binding affinities and interaction profiles. The docking results demonstrated that selected peptides exhibited strong binding affinity toward the catalytic pocket of LTP-1, forming stable hydrogen bonds and hydrophobic interactions. Energy scoring revealed favorable binding energies ranging from −6.5 to −10.2 kcal/mol. These findings highlight the potential of peptide-based inhibitors targeting LTP-1 in P. gingivalis as a novel therapeutic approach for periodontal disease management. Further in vitro and in vivo validation studies are warranted to translate these findings into clinical applications..
Downloads
References
[1] Pihlstrom BL, Michalowicz BS, Johnson NW. Periodontal diseases. Lancet. 2005;366:1809–1820.
[2] Kinane DF, Stathopoulou PG, Papapanou PN. Periodontal diseases. Nat Rev Dis Primers. 2017;3:17038.
[3] Hajishengallis G. Periodontitis: from microbial immune subversion to systemic inflammation. Nat Rev Immunol. 2015;15:30–44.
[4] Tonks NK. Protein tyrosine phosphatases: from genes to function. Nat Rev Mol Cell Biol. 2006;7:833–846.
[5] Slots J. Antibiotics in periodontics. J Periodontol. 2002;73:1553–1565.
[6] Hancock RE, Sahl HG. Antimicrobial peptides. Nat Biotechnol. 2006;24:1551–1557.
[7] Morris GM, Lim-Wilby M. Molecular docking. Methods Mol Biol. 2008;443:365–382.
[8] Berman HM et al. Protein Data Bank. Nucleic Acids Res. 2000;28:235–242.
[9] Wang G et al. APD3 database. Nucleic Acids Res. 2016;44:D1087–D1093.
[10] Kozakov D et al. ClusPro docking server. Nat Protoc. 2017;12:255–278.
[11] DeLano WL. PyMOL molecular graphics system.
[12] Meng XY et al. Molecular docking overview. Curr Comput Aided Drug Des. 2011;7:146–157.
[13] Jenssen H et al. Peptide antimicrobial agents. Clin Microbiol Rev. 2006;19:491–511.
[14] Mookherjee N et al. Immunomodulatory peptides. Nat Rev Drug Discov. 2020;19:311–332.
Downloads
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.